Table 1 Clinical characteristics
Characteristics | Value |
|---|---|
Patients | 38 |
Age, y | Â |
   Median | 41 |
   Range | (11–68) |
Sex | Â |
   Male | 22 |
   Female | 16 |
Diagnosis | Â |
   Acute leukemia | 16 |
   Lymphoma | 6 |
   Multiple myeloma | 4 |
   Myelodyspastic syndrome | 4 |
   Solid tumor | 4 |
   Non neoplastic disorders | 3 |
   Chronic lynphocytid leukemia | 1 |
Acute GVHD | Â |
   0–I | 27 |
   II–IV | 11 |
Total body irradiation | Â |
   Yes | 15 |
   No | 23 |
Conditioning regimen | Â |
   Standard | 25 |
   Reduced intensity conditioning | 13 |
Type of transplant | Â |
   Related | 30 |
   Unrelated | 8 |
Hemopoietic reconstitution | Â |
   Median days of PMN >0.5 × 109/L (range) | 16 (11 – 41) |
   Median days of PLTS >20 × 109/L (range) | 15 (9 – 65) |
   Median days of PLTS >50 × 109/L (range) | 18 (11 – 88) |
Source of stem cells | Â |
   Peripheral blood | 31 |
   Bone marrow | 4 |
   Cord blood | 3 |
Prophylaxis of aGVHD | Â |
   CyA+MTX | 25 |
   CyA+MMF | 6 |
   CyA+PDN | 4 |
   Other | 3 |
CMV status (donor/recipient) | Â |
   Positive/positive | 26 |
   Negative/positive | 10 |
   Positive/negative | 2 |
Deaths | 4 |